KR101228552B1 - 마늘 함유 발효 식품소재 및 이의 제조방법 - Google Patents
마늘 함유 발효 식품소재 및 이의 제조방법 Download PDFInfo
- Publication number
- KR101228552B1 KR101228552B1 KR1020120022650A KR20120022650A KR101228552B1 KR 101228552 B1 KR101228552 B1 KR 101228552B1 KR 1020120022650 A KR1020120022650 A KR 1020120022650A KR 20120022650 A KR20120022650 A KR 20120022650A KR 101228552 B1 KR101228552 B1 KR 101228552B1
- Authority
- KR
- South Korea
- Prior art keywords
- garlic
- lactic acid
- acid bacteria
- medium
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000004611 garlic Nutrition 0.000 title claims abstract description 158
- 239000000463 material Substances 0.000 title claims abstract description 20
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 18
- 235000013305 food Nutrition 0.000 title abstract description 17
- 244000245420 ail Species 0.000 title 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 162
- 240000002234 Allium sativum Species 0.000 claims abstract description 157
- 241000894006 Bacteria Species 0.000 claims abstract description 82
- 239000004310 lactic acid Substances 0.000 claims abstract description 81
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 81
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 71
- 244000068988 Glycine max Species 0.000 claims abstract description 56
- 235000021107 fermented food Nutrition 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 17
- 235000013312 flour Nutrition 0.000 claims description 20
- 235000000346 sugar Nutrition 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 8
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 8
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 7
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 6
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 6
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 6
- 244000057717 Streptococcus lactis Species 0.000 claims description 4
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 3
- 230000008961 swelling Effects 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 2
- 235000013322 soy milk Nutrition 0.000 abstract description 33
- 239000000843 powder Substances 0.000 abstract description 20
- 239000006041 probiotic Substances 0.000 abstract description 19
- 235000018291 probiotics Nutrition 0.000 abstract description 19
- 239000004480 active ingredient Substances 0.000 abstract description 10
- 235000016127 added sugars Nutrition 0.000 abstract description 2
- 235000019633 pungent taste Nutrition 0.000 abstract description 2
- 238000000855 fermentation Methods 0.000 description 52
- 230000004151 fermentation Effects 0.000 description 52
- 239000002609 medium Substances 0.000 description 41
- 230000002292 Radical scavenging effect Effects 0.000 description 32
- 239000000523 sample Substances 0.000 description 28
- 235000021109 kimchi Nutrition 0.000 description 20
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 17
- 239000000047 product Substances 0.000 description 14
- 230000003078 antioxidant effect Effects 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 235000019654 spicy taste Nutrition 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 230000001965 increasing effect Effects 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 239000012153 distilled water Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 230000002265 prevention Effects 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 6
- XJRPTMORGOIMMI-UHFFFAOYSA-N ethyl 2-amino-4-(trifluoromethyl)-1,3-thiazole-5-carboxylate Chemical compound CCOC(=O)C=1SC(N)=NC=1C(F)(F)F XJRPTMORGOIMMI-UHFFFAOYSA-N 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 150000007524 organic acids Chemical class 0.000 description 6
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 230000002000 scavenging effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 239000006000 Garlic extract Substances 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 235000020706 garlic extract Nutrition 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 235000008696 isoflavones Nutrition 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 108020004465 16S ribosomal RNA Proteins 0.000 description 3
- 240000007124 Brassica oleracea Species 0.000 description 3
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 3
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 3
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 238000004255 ion exchange chromatography Methods 0.000 description 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 235000019629 palatability Nutrition 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- IXELFRRANAOWSF-FNORWQNLSA-N (E)-Ajoene Chemical compound C=CCSS\C=C\CS(=O)CC=C IXELFRRANAOWSF-FNORWQNLSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- -1 ABTS radicals Chemical class 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- 235000007862 Capsicum baccatum Nutrition 0.000 description 2
- UBJVUCKUDDKUJF-UHFFFAOYSA-N Diallyl sulfide Chemical compound C=CCSCC=C UBJVUCKUDDKUJF-UHFFFAOYSA-N 0.000 description 2
- 241000194032 Enterococcus faecalis Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000186869 Lactobacillus salivarius Species 0.000 description 2
- 241000194041 Lactococcus lactis subsp. lactis Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 244000100170 Phaseolus lunatus Species 0.000 description 2
- 235000010617 Phaseolus lunatus Nutrition 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014969 Streptococcus diacetilactis Nutrition 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- IXELFRRANAOWSF-CYBMUJFWSA-N ajoene Natural products C=CCSSC=CC[S@](=O)CC=C IXELFRRANAOWSF-CYBMUJFWSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000010170 biological method Methods 0.000 description 2
- 239000001728 capsicum frutescens Substances 0.000 description 2
- IXELFRRANAOWSF-UHFFFAOYSA-N cis-ajoene Natural products C=CCSSC=CCS(=O)CC=C IXELFRRANAOWSF-UHFFFAOYSA-N 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 230000002079 cooperative effect Effects 0.000 description 2
- PFRGXCVKLLPLIP-UHFFFAOYSA-N diallyl disulfide Chemical compound C=CCSSCC=C PFRGXCVKLLPLIP-UHFFFAOYSA-N 0.000 description 2
- UBAXRAHSPKWNCX-UHFFFAOYSA-N diallyl trisulfide Chemical compound C=CCSSSCC=C UBAXRAHSPKWNCX-UHFFFAOYSA-N 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229940032049 enterococcus faecalis Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 238000001139 pH measurement Methods 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 241000383638 Allium nigrum Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241001454694 Clupeiformes Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 230000007023 DNA restriction-modification system Effects 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 201000003741 Gastrointestinal carcinoma Diseases 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 241001104448 Lactobacillus kunkeei DSM 12361 = ATCC 700308 Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- 241000408529 Libra Species 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 241000186429 Propionibacterium Species 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 108020001027 Ribosomal DNA Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000008049 biological aging Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000007366 host health Effects 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 235000021574 pickled cabbage Nutrition 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/28—Removal of unwanted matter, e.g. deodorisation or detoxification using microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Preparation Of Fruits And Vegetables (AREA)
Abstract
Description
Claims (8)
- 설탕과 콩이 10 ~ 30중량% 함유된 배지를 오토클레이브(autoclave)에서 멸균한 후 방냉하는 단계;
방냉된 상기 배지에 배지 중량의 10~20중량%의 미분쇄 마늘을 첨가하는 단계;
마늘이 첨가된 상기 배지를 50~70℃에서 20~30분간 가열하여 살균하는 단계; 및
살균된 상기 배지에 Lactobacillus acidophilus, Lactococcus lactis subsp. lactis, Lactobacillus plantarum 중 적어도 하나의 유산균을 접종한 후 5 ~ 7일간 발효시키는 단계를 포함하는 마늘 함유 발효 식품소재의 제조방법. - 제 1항에 있어서,
상기 유산균은 상기 배지의 1 ~ 10중량% 접종되는 것을 특징으로 하는 마늘 함유 발효 식품소재의 제조방법. - 제 1항에 있어서,
상기 배지는 콩 질량의 8 ~ 20배의 물을 가하여 상기 콩을 팽윤시킨 후 마쇄시킨 것 또는 콩가루 함량이 8 ~ 20중량% 포함된 것 중 적어도 하나를 사용하며,
상기 배지에 함유된 설탕은 2 ~ 10중량%인 것을 특징으로 하는 마늘 함유 발효 식품소재의 제조방법. - 제 1항의 제조방법에 의해 제조된 마늘 함유 발효 식품소재.
- 삭제
- 삭제
- 삭제
- 삭제
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020120022650A KR101228552B1 (ko) | 2012-03-06 | 2012-03-06 | 마늘 함유 발효 식품소재 및 이의 제조방법 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020120022650A KR101228552B1 (ko) | 2012-03-06 | 2012-03-06 | 마늘 함유 발효 식품소재 및 이의 제조방법 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR101228552B1 true KR101228552B1 (ko) | 2013-02-01 |
Family
ID=47898695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020120022650A Active KR101228552B1 (ko) | 2012-03-06 | 2012-03-06 | 마늘 함유 발효 식품소재 및 이의 제조방법 |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR101228552B1 (ko) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20160028735A (ko) | 2014-09-04 | 2016-03-14 | 김성수 | 소이바이오틱스 유산균생산물질을 함유하는 발효 흑마늘 요구르트 및 이의 제조방법 |
| KR101988878B1 (ko) * | 2017-12-19 | 2019-06-14 | 강원대학교산학협력단 | 풍미와 항산화 및 면역기능이 증진된 고체발효마늘 조성물 및 이의 제조방법 |
| KR20210028388A (ko) * | 2019-09-04 | 2021-03-12 | 윤심 | 유산균 발효 마늘 조성물의 제조방법 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100716133B1 (ko) * | 2006-08-17 | 2007-05-08 | 주식회사 신원에프아이 | 자극적 향미가 완화된 건강 증진용 마늘 소재 및 이의제조방법 |
| JP2010252662A (ja) | 2009-04-23 | 2010-11-11 | Enseki Aojiru Kk | 無臭大蒜の製造方法及びその無臭大蒜 |
| KR20110022280A (ko) * | 2009-08-27 | 2011-03-07 | 주식회사 바이오랜드 | 유산균을 이용한 sac 고함량 마늘 발효물의 제조방법 |
-
2012
- 2012-03-06 KR KR1020120022650A patent/KR101228552B1/ko active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100716133B1 (ko) * | 2006-08-17 | 2007-05-08 | 주식회사 신원에프아이 | 자극적 향미가 완화된 건강 증진용 마늘 소재 및 이의제조방법 |
| JP2010252662A (ja) | 2009-04-23 | 2010-11-11 | Enseki Aojiru Kk | 無臭大蒜の製造方法及びその無臭大蒜 |
| KR20110022280A (ko) * | 2009-08-27 | 2011-03-07 | 주식회사 바이오랜드 | 유산균을 이용한 sac 고함량 마늘 발효물의 제조방법 |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20160028735A (ko) | 2014-09-04 | 2016-03-14 | 김성수 | 소이바이오틱스 유산균생산물질을 함유하는 발효 흑마늘 요구르트 및 이의 제조방법 |
| KR101988878B1 (ko) * | 2017-12-19 | 2019-06-14 | 강원대학교산학협력단 | 풍미와 항산화 및 면역기능이 증진된 고체발효마늘 조성물 및 이의 제조방법 |
| KR20210028388A (ko) * | 2019-09-04 | 2021-03-12 | 윤심 | 유산균 발효 마늘 조성물의 제조방법 |
| KR102307191B1 (ko) * | 2019-09-04 | 2021-09-30 | 윤심 | 유산균 발효 마늘 조성물의 제조방법 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Behera et al. | Lactobacillus plantarum with functional properties: an approach to increase safety and shelf‐life of fermented foods | |
| La Anh | Health-promoting microbes in traditional Vietnamese fermented foods: A review | |
| KR101518106B1 (ko) | 신규한 균주 바실러스 아밀로리쿼페이션스 cj 3―27 및 아스퍼질러스 오리재 cj kg를 이용한 한식 메주된장의 제조방법 | |
| M’hir et al. | Technological, functional and safety aspects of enterococci in fermented vegetable products: a mini-review | |
| KR101799424B1 (ko) | 황기 발효산물 및 그것의 제조 방법 | |
| US12419327B2 (en) | Method for preparing feed by bacteria-enzyme synergistic fermentation | |
| Sharma et al. | Microbiology of khorisa, its proximate composition and probiotic potential of lactic acid bacteria present in Khorisa, a traditional fermented Bamboo shoot product of Assam | |
| Zhang et al. | Evaluation and application of different cholesterol-lowering lactic acid bacteria as potential meat starters | |
| KR102677848B1 (ko) | 김치 발효용 프로바이오틱스 및 이를 활용한 김치 | |
| Adeyemo et al. | Reduction of Anti-nutritional factors of sorghum by lactic acid bacteria isolated from Abacha-an African fermented staple | |
| KR101228552B1 (ko) | 마늘 함유 발효 식품소재 및 이의 제조방법 | |
| KR101451810B1 (ko) | 감마-아미노부티르산 생산능이 우수한 신규한 락토바실러스 플랜타룸 k255 균주 | |
| KR101757223B1 (ko) | 생리활성 기능성이 향상된 감귤 발효물 제조방법 | |
| KR101562653B1 (ko) | 바실러스 서브틸리스 cs135 균주 및 이를 이용한 여주 청국장 제조방법 | |
| KR20110118492A (ko) | 글루타치온 함량이 증대된 신규 효모 변이주, 그 제조 방법 및 용도 | |
| KR20120124080A (ko) | 두유식혜요구르트의 제조방법 및 이 방법에 의해 제조된 두유식혜요구르트 | |
| Onipede et al. | Influence of starter culture lactic acid bacteria on the phytic acid content of sorghum-ogi (an indigenous cereal gruel). | |
| JP6853624B2 (ja) | 新規な植物性乳酸菌 | |
| KR102335219B1 (ko) | 흰점박이꽃무지의 염장 발효식품 및 이의 제조방법 | |
| KR101673055B1 (ko) | 신규한 스타터 균주 및 이를 이용한 두부를 포함하는 기능성 발효식품의 제조방법 | |
| KR101755789B1 (ko) | 비타민 c를 이용한 콩 발효물의 제조방법 | |
| Sekwati-Monang | Microbiological and chemical characterisation of ting, a sorghum-based gluten-free fermented cereal product from Botswana | |
| KR101871904B1 (ko) | 류코노스톡 메센테로이데스 ysm1219 균주 및 이의 용도 | |
| Abimbola et al. | Production of Fermented Cassava Flour (Lafun) using Lactic Acid Bacteria as Starter Culture | |
| Nayem | Screening of lactic acid bacteria that have health promoting effect from Thai local fermented foods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| A302 | Request for accelerated examination | ||
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20120306 |
|
| PA0201 | Request for examination | ||
| PA0302 | Request for accelerated examination |
Patent event date: 20120306 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20120620 Patent event code: PE09021S01D |
|
| E90F | Notification of reason for final refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Final Notice of Reason for Refusal Patent event date: 20121123 Patent event code: PE09021S02D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20130123 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20130125 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20130128 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| FPAY | Annual fee payment |
Payment date: 20161121 Year of fee payment: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20161121 Start annual number: 5 End annual number: 5 |
|
| FPAY | Annual fee payment |
Payment date: 20171106 Year of fee payment: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 20171106 Start annual number: 6 End annual number: 6 |
|
| FPAY | Annual fee payment |
Payment date: 20191016 Year of fee payment: 8 |
|
| PR1001 | Payment of annual fee |
Payment date: 20191016 Start annual number: 8 End annual number: 8 |
|
| PR1001 | Payment of annual fee |
Payment date: 20201020 Start annual number: 9 End annual number: 9 |
|
| PR1001 | Payment of annual fee |
Payment date: 20240118 Start annual number: 12 End annual number: 12 |
|
| PR1001 | Payment of annual fee |
Payment date: 20250107 Start annual number: 13 End annual number: 13 |

















